Background: This study aims to investigate the effect of ropivacaine
combined with sufentanil on hemodynamics and expression levels of serum tumor
necrosis factor- (TNF-) and interleukin-6 (IL-6) in
parturients undergoing cesarean section. Methods: The clinical data of
135 parturients undergoing cesarean section were retrospectively collected. After
anesthesia, 135 parturients were divided into observation group (68 cases) and
control group (67 cases). The observation group was anesthetized with ropivacaine
combined with sufentanil before operation, while the control group was
anesthetized with ropivacaine. Anesthesia related indexes, hemodynamics at
different times and arterial blood gas analysis indexes of the two groups were
observed and recorded. The peripheral venous blood of the two groups was taken 1
day before delivery, 12 hours after delivery and 24 hours after delivery to
detect expression levels of TNF- and IL-6. The Apgar scores of the two
groups of newborns were recorded at 1 and 5 minutes after delivery, respectively.
Results: Compared with the control group, the observation group had a
shorter time to reach the maximum block plane, a longer time to maintain
analgesia, and a lower visual analog scale (VAS) score at 6 h postpartum
(p 0.05). Moreover, the mean arterial pressure (MAP) and heart rate
(HR) during skin resection (T) in the observation group were higher
(p 0.05), and the cardiac output (CO), stroke volume (SV) and
systemic circulation resistance (SVR) during T and end of surgery (T)
in the observation group were higher (p 0.05). PaCO was
increased and PaO in the control group at T and T was decreased
after anesthesia (p 0.05). Compared with 1 day before delivery, the
serum levels of TNF- and IL-6 increased at 12 and 24 hours after
delivery. Compared with the control group, the serum levels of TNF- and
IL-6 in the observation group were lower at 12 and 24 hours after delivery
(p 0.05). Conclusions: The anesthetic effect of ropivacaine
combined with sufentanil before cesarean section is better, which can effectively
stabilize the mean arterial pressure, heart rate and other hemodynamic indicators
of the puerpera, inhibit the inflammation in the puerpera, and have no adverse
effects on the newborn.